The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases

By  

Digestive Diseases, Vol. 30, Iss. 3, 2012-06 ,pp. : 289-295

Karger

Access to resources Recommend Favorite

Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer

By Shim Ki-Nam   Jung Sung-Ae   Joo Yang-Hee   Yoo Kwon  

Journal of Gastroenterology, Vol. 42, Iss. 2, 2007-02 ,pp. : 120-128

Springer Publishing Company

Access to resources Recommend Favorite

Serum Levels of Matrix Metalloproteinases-2 and -9 and Their Tissue Inhibitors in Inflammatory Neuromuscular Disorders

By  

European Neurology, Vol. 55, Iss. 4, 2006-08 ,pp. : 204-208

Karger

Access to resources Recommend Favorite

Matrix Metalloproteinases and their Inhibitors in Hypertensive Cardiac Remodelling

By Marchesi Chiara   Maresca Andrea M.   Grandi Anna M.  

High Blood Pressure & Cardiovascular Prevention, Vol. 17, Iss. 4, 2010-12 ,pp. : 201-208

Adis International

Access to resources Recommend Favorite

Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis

By Salata Ireneusz   Stojanovic Nemanja   Cajdler-Łuba Agata   Lewandowski Krzysztof   Lewinski Andrzej  

Gynecological Endocrinology, Vol. 24, Iss. 6, 2008-01 ,pp. : 326-330

Informa Healthcare

Access to resources Recommend Favorite